{"id":"calcium-folinate-injection","safety":{"commonSideEffects":[{"rate":null,"effect":"Allergic reactions"},{"rate":null,"effect":"Nausea and vomiting"},{"rate":null,"effect":"Diarrhea"},{"rate":null,"effect":"Stomatitis"}]},"_chembl":null,"_dailymed":null,"mechanism":{"_ai_source":"claude-haiku-4.5","explanation":"Calcium folinate (leucovorin) is the active, reduced form of folic acid that bypasses the enzymatic reduction step required to convert dietary folate into its active form. It serves as a methyl donor and cofactor in nucleotide synthesis, supporting DNA replication and repair. It is commonly used as a rescue agent in high-dose methotrexate therapy and as an adjunct in cancer chemotherapy regimens.","oneSentence":"Calcium folinate is a reduced form of folic acid that acts as a cofactor in one-carbon transfer reactions, supporting DNA synthesis and cell division.","_ai_confidence":"high"},"_scrapedAt":"2026-03-28T01:04:45.063Z","_scrapedBy":"cloudflare-swarm","_wikipedia":null,"indications":{"approved":[{"name":"Methotrexate toxicity rescue in high-dose methotrexate chemotherapy"},{"name":"Adjunctive therapy in colorectal cancer and other malignancies"},{"name":"Megaloblastic anemia due to folate deficiency"}]},"trialDetails":[{"nctId":"NCT06469944","phase":"PHASE1, PHASE2","title":"Substudy 06C: A Study of Investigational Agents With Pembrolizumab (MK-3475) and Chemotherapy in Participants With First-Line Locally Advanced Unresectable/Metastatic Gastroesophageal Adenocarcinoma (MK-3475-06C/KEYMAKER-U06)","status":"RECRUITING","sponsor":"Merck Sharp & Dohme LLC","startDate":"2024-09-20","conditions":"Gastroesophageal Junction, Gastroesophageal Adenocarcinoma, Esophageal Neoplasms","enrollment":160},{"nctId":"NCT05292664","phase":"PHASE1","title":"Venetoclax Basket Trial for High Risk Hematologic Malignancies","status":"RECRUITING","sponsor":"Andrew E. Place, MD","startDate":"2023-03-29","conditions":"Myelodysplastic Syndromes, de Novo, Myelodysplastic Syndromes, Secondary, Myelodysplastic Syndromes, Previously Treated","enrollment":30},{"nctId":"NCT04083235","phase":"PHASE3","title":"A Study to Assess the Effectiveness and Safety of Irinotecan Liposome Injection, 5-fluorouracil/Leucovorin Plus Oxaliplatin in Patients Not Previously Treated for Metastatic Pancreatic Cancer, Compared to Nab-paclitaxel+Gemcitabine Treatment","status":"COMPLETED","sponsor":"Ipsen","startDate":"2020-02-11","conditions":"Metastatic Adenocarcinoma of the Pancreas","enrollment":770},{"nctId":"NCT05846867","phase":"PHASE1, PHASE2","title":"A Phase Ib/II Clinical Study on AK112 Combined or Not Combined With AK119 in pMMR/MSS Colorectal Cancer","status":"ACTIVE_NOT_RECRUITING","sponsor":"Akeso","startDate":"2023-05-08","conditions":"Colorectal Cancer","enrollment":170},{"nctId":"NCT03801876","phase":"PHASE3","title":"Comparing Proton Therapy to Photon Radiation Therapy for Esophageal Cancer","status":"RECRUITING","sponsor":"NRG Oncology","startDate":"2019-06-26","conditions":"Clinical Stage I Esophageal Adenocarcinoma AJCC v8, Clinical Stage I Esophageal Squamous Cell Carcinoma AJCC v8, Clinical Stage I Gastroesophageal Junction Adenocarcinoma AJCC v8","enrollment":300},{"nctId":"NCT07229846","phase":"PHASE2","title":"A Single-arm, Single-center, Phase II Clinical Study of Aipalolitovorelizumab (QL1706) Combined With Bevacizumab and Standard Chemotherapy as First-line Treatment for MSS/pMMR Metastatic Colorectal Cancer With BRAF V600E Mutation","status":"NOT_YET_RECRUITING","sponsor":"Yanqiao Zhang","startDate":"2026-02","conditions":"Colorectal Cancer","enrollment":30},{"nctId":"NCT07298772","phase":"PHASE1, PHASE2","title":"A Study of SHR-4375 Injection in Combination With Other Antitumor Therapies in Patients With Solid Tumors","status":"NOT_YET_RECRUITING","sponsor":"Suzhou Suncadia Biopharmaceuticals Co., Ltd.","startDate":"2025-12","conditions":"Advanced Solid Tumor","enrollment":198},{"nctId":"NCT04396821","phase":"PHASE1, PHASE2","title":"A Trial to Evaluate Safety and Tolerability of TST001 in Advanced or Metastatic Solid Tumors","status":"ACTIVE_NOT_RECRUITING","sponsor":"Suzhou Transcenta Therapeutics Co., Ltd.","startDate":"2020-05-28","conditions":"Advanced Cancer, Gastric Cancer, Gastroesophageal-junction Cancer","enrollment":150},{"nctId":"NCT07238283","phase":"PHASE3","title":"Irinotecan Hydrochloride Liposome Injection (II)in Combination With Oxaliplatin, 5-FU/LV Versus AG for First-line Treatment of Metastatic Pancreatic Cancer","status":"RECRUITING","sponsor":"Jiangsu HengRui Medicine Co., Ltd.","startDate":"2025-12-02","conditions":"First-line Treatment of Metastatic Pancreatic Cancer","enrollment":662},{"nctId":"NCT06703177","phase":"PHASE1, PHASE2","title":"A Study of SHR-1826 for Injection in Combination With Other Antitumor Therapies in Subjects With Solid Tumors","status":"RECRUITING","sponsor":"Suzhou Suncadia Biopharmaceuticals Co., Ltd.","startDate":"2025-02-18","conditions":"Advanced Solid Tumors","enrollment":876},{"nctId":"NCT07262567","phase":"PHASE3","title":"Phase III Study to Compare GFH375 and Chemotherapy in Patients With KRAS G12D-Mutant Metastatic Pancreatic Cancer","status":"NOT_YET_RECRUITING","sponsor":"Genfleet Therapeutics (Shanghai) Inc.","startDate":"2025-12","conditions":"Metastatic Pancreatic Cancer","enrollment":320},{"nctId":"NCT05836584","phase":"PHASE2","title":"Testing Immunotherapy (Atezolizumab) With or Without Chemotherapy in Locoregional MSI-H/dMMR Gastric and Gastroesophageal Junction (GEJ) Cancer","status":"ACTIVE_NOT_RECRUITING","sponsor":"National Cancer Institute (NCI)","startDate":"2023-12-06","conditions":"Clinical Stage I Gastric Cancer AJCC v8, Clinical Stage I Gastroesophageal Junction Adenocarcinoma AJCC v8, Clinical Stage II Gastric Cancer AJCC v8","enrollment":240},{"nctId":"NCT04141995","phase":"PHASE2","title":"FOLFIRINOX With Digoxin in Patients With Resectable Pancreatic Cancer","status":"TERMINATED","sponsor":"University of Nebraska","startDate":"2021-02-12","conditions":"Pancreas Cancer, Adenocarcinoma of the Pancreas","enrollment":11},{"nctId":"NCT04861558","phase":"PHASE3","title":"Efficacy of Hyperthermic Intraperitoneal Chemotherapy","status":"RECRUITING","sponsor":"Uppsala University","startDate":"2021-05-01","conditions":"Colorectal Cancer, Peritoneal Metastases","enrollment":213},{"nctId":"NCT06993025","phase":"PHASE2","title":"Ivonescimab in Combination With Liposomal Irinotecan and 5-FU/LV in Potentially Resectable Biliary Tract Malignancies","status":"NOT_YET_RECRUITING","sponsor":"Tianjin Medical University Cancer Institute and Hospital","startDate":"2025-05-25","conditions":"Biliary Tract Cancer","enrollment":30},{"nctId":"NCT06959693","phase":"PHASE2, PHASE3","title":"A Clinical Study to Evaluate the Efficacy and Safety of Envafolimab Combined With Cetuxima-βand mFOLFOX6 in Patients With MSS, RAS/BRAF Wild-Type Metastatic Colorectal Cancer (mCRC)","status":"NOT_YET_RECRUITING","sponsor":"Sun Yat-sen University","startDate":"2025-06-01","conditions":"Metastatic Colorectal Cancer (CRC)","enrollment":590},{"nctId":"NCT04796948","phase":"PHASE1","title":"A Study of Irinotecan Liposome in Advanced Pancreatic Cancer","status":"COMPLETED","sponsor":"Jiangsu HengRui Medicine Co., Ltd.","startDate":"2021-04-08","conditions":"Advanced Pancreatic Cancer","enrollment":41},{"nctId":"NCT06572813","phase":"PHASE1, PHASE2","title":"Bortezomib Combined with PD-1 MAb and MFOLFIRINOX for Metastatic Pancreatic Cancer","status":"RECRUITING","sponsor":"Zhejiang University","startDate":"2024-11-15","conditions":"Pancreas Cancer","enrollment":63},{"nctId":"NCT03563157","phase":"PHASE1, PHASE2","title":"QUILT 3.071: NANT Colorectal Cancer (CRC) Vaccine","status":"TERMINATED","sponsor":"ImmunityBio, Inc.","startDate":"2018-09-28","conditions":"Colorectal Cancer Metastatic, mCRC","enrollment":2},{"nctId":"NCT06094140","phase":"PHASE2","title":"NEO-adjuvant Chemo-immunotherapy in Pancreatic Cancer","status":"ACTIVE_NOT_RECRUITING","sponsor":"Australasian Gastro-Intestinal Trials Group","startDate":"2022-05-20","conditions":"Pancreatic Cancer","enrollment":20},{"nctId":"NCT06531278","phase":"PHASE2","title":"Adebelimab Combined With Irinotecan Liposomal Injection, Oxaliplatin, Fluorouracil and Calcium Folinate Are Used in the First-line Treatment of Pancreatic Cancer Liver Metastasis Efficacy and Safety","status":"RECRUITING","sponsor":"Jiang Long","startDate":"2024-07-16","conditions":"Pancreatic Cancer Metastatic to Liver","enrollment":40},{"nctId":"NCT06375317","phase":"PHASE2","title":"HAIC Combined With PD-L1 Plus Regorafenib in the Treatment of Advanced Hepatocellular Carcinoma After Immunotherapy Failure","status":"NOT_YET_RECRUITING","sponsor":"Yehua Shen","startDate":"2024-04-30","conditions":"HCC - Hepatocellular Carcinoma","enrollment":42},{"nctId":"NCT06365008","phase":"PHASE2","title":"Sintilimab Plus FOLFIRI as Salvage Therapy for Patients With Advanced Gastric Cancer","status":"RECRUITING","sponsor":"Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University","startDate":"2024-04-08","conditions":"Unresectable/Metastatic Gastric Cancer","enrollment":40},{"nctId":"NCT06363552","phase":"PHASE2","title":"A Study of SC-0191 in Subjects With Metastatic Colorectal Cancer","status":"NOT_YET_RECRUITING","sponsor":"Tianshu Liu","startDate":"2024-05","conditions":"Metastatic Colorectal Cancer","enrollment":36},{"nctId":"NCT03127124","phase":"PHASE1, PHASE2","title":"QUILT-2.022 NANT-008 in Combination w/ 5-fluorouracil, Bevacizumab, Leucovorin & Oxaliplatin in Subjects With Pancreatic Cancer","status":"WITHDRAWN","sponsor":"NantPharma, LLC","startDate":"2018-02-27","conditions":"Pancreatic Adenocarcinoma Metastatic","enrollment":""},{"nctId":"NCT05148195","phase":"PHASE2","title":"A Phase II Study of Envofolimab and BD0801 With/Without Chemotherapy in Patients With Advanced Solid Tumors","status":"TERMINATED","sponsor":"Jiangsu Simcere Pharmaceutical Co., Ltd.","startDate":"2021-12-22","conditions":"Advanced Solid Tumor","enrollment":86},{"nctId":"NCT05015621","phase":"PHASE3","title":"A Phase 3 Study to Evaluate Surufatinib Plus Toripalimab in the Treatment of Advanced Neuroendocrine Carcinoma","status":"UNKNOWN","sponsor":"Hutchison Medipharma Limited","startDate":"2021-09-18","conditions":"Advanced Neuroendocrine Carcinoma","enrollment":194},{"nctId":"NCT01133990","phase":"PHASE1, PHASE2","title":"FOLFIRI Alone Versus FOLFIRI Plus Bevacizumab Versus FOLFIRI Plus E7820 as Second-Line Therapy in Patients With Locally Advanced or Metastatic Colorectal Cancer","status":"TERMINATED","sponsor":"Eisai Inc.","startDate":"2010-03-04","conditions":"Colorectal Cancer","enrollment":5},{"nctId":"NCT00039130","phase":"PHASE2","title":"Rituximab, Chemotherapy, and Filgrastim in Treating Patients With Burkitt's Lymphoma or Burkitt's Leukemia","status":"COMPLETED","sponsor":"Alliance for Clinical Trials in Oncology","startDate":"2002-05","conditions":"Leukemia, Lymphoma","enrollment":105},{"nctId":"NCT05872841","phase":"PHASE2","title":"H101 Combined With TACE for Primary Hepatocellular Carcinoma With Portal Vein Thrombosis","status":"UNKNOWN","sponsor":"Tianjin Medical University Cancer Institute and Hospital","startDate":"2023-06-01","conditions":"Primary Hepatocellular Carcinoma, Portal Vein Thrombosis","enrollment":38},{"nctId":"NCT03577704","phase":"PHASE1, PHASE2","title":"The Safety,Efficacy of Anti-EGFR Humanized Monoclonal Antibody Combined With Chemotherapy in Advanced Solid Tumors.","status":"COMPLETED","sponsor":"Shanghai Henlius Biotech","startDate":"2018-08-08","conditions":"Advanced Solid Tumors","enrollment":56},{"nctId":"NCT05480280","phase":"PHASE2","title":"mFOLFOX6 Combined With Dalpiciclib in Patients With Metastatic Colorectal Cancer","status":"UNKNOWN","sponsor":"Sixth Affiliated Hospital, Sun Yat-sen University","startDate":"2022-07-20","conditions":"Advanced/Metastatic Colorectal Cancer","enrollment":18},{"nctId":"NCT03050814","phase":"PHASE2","title":"Standard of Care Alone or in Combination With Ad-CEA Vaccine and Avelumab in People With Previously Untreated Metastatic Colorectal Cancer QUILT-2.004","status":"TERMINATED","sponsor":"National Cancer Institute (NCI)","startDate":"2017-04-05","conditions":"Colorectal Tumors, Colorectal Neoplasms, Colorectal Carcinoma","enrollment":30},{"nctId":"NCT00000998","phase":"PHASE1","title":"A Study of Trimetrexate in the Treatment of Pneumocystis Carinii Pneumonia (PCP) in Patients With AIDS Not Previously Treated for PCP","status":"COMPLETED","sponsor":"National Institute of Allergy and Infectious Diseases (NIAID)","startDate":"","conditions":"Pneumonia, Pneumocystis Carinii, HIV Infections","enrollment":50},{"nctId":"NCT00000689","phase":"PHASE1","title":"Phase I Trial of mBACOD and Granulocyte-Macrophage Colony-Stimulating Factor (GM-CSF) in AIDS-Associated Large Cell, Immunoblastic, and Small Non-cleaved Lymphoma","status":"COMPLETED","sponsor":"National Institute of Allergy and Infectious Diseases (NIAID)","startDate":"","conditions":"Lymphoma, Non-Hodgkin, HIV Infections","enrollment":18},{"nctId":"NCT00103285","phase":"PHASE3","title":"Combination Chemotherapy in Treating Young Patients With Newly Diagnosed Acute Lymphoblastic Leukemia","status":"COMPLETED","sponsor":"Children's Oncology Group","startDate":"2005-04-11","conditions":"Acute Lymphoblastic Leukemia, Childhood B Acute Lymphoblastic Leukemia","enrollment":5377},{"nctId":"NCT00075725","phase":"PHASE3","title":"Dexamethasone Compared With Prednisone During Induction Therapy and Methotrexate With or Without Leucovorin During Maintenance Therapy in Treating Patients With Newly Diagnosed High-Risk Acute Lymphoblastic Leukemia","status":"COMPLETED","sponsor":"Children's Oncology Group","startDate":"2003-12-29","conditions":"Acute Lymphoblastic Leukemia, Adult B Acute Lymphoblastic Leukemia, Childhood B Acute Lymphoblastic Leukemia","enrollment":3154},{"nctId":"NCT03563170","phase":"PHASE1, PHASE2","title":"QUILT-3.072: NANT Hepatocellular Carcinoma (HCC) Vaccine","status":"WITHDRAWN","sponsor":"ImmunityBio, Inc.","startDate":"2018-05-25","conditions":"Hepatocellular Carcinoma Non-resectable, Hepatocellular Carcinoma Recurrent","enrollment":""},{"nctId":"NCT04479527","phase":"PHASE2","title":"Evaluation Effectiveness and Safety of (cTACE or DEB-TACE + FOLFOX Regimen HAIC) Combined With Camrelizumab and Apatinib Mesylas in the Treatment of Advanced Hepatocellular Carcinoma","status":"UNKNOWN","sponsor":"Peking University Cancer Hospital & Institute","startDate":"2021-04","conditions":"Hepatocellular Carcinoma","enrollment":34},{"nctId":"NCT00002570","phase":"PHASE3","title":"Immediate Compared With Delayed Chemotherapy in Advanced Colorectal Cancer Without Signs or Symptoms of Disease","status":"COMPLETED","sponsor":"NCIC Clinical Trials Group","startDate":"1994-07-15","conditions":"Colorectal Cancer","enrollment":67},{"nctId":"NCT00077233","phase":"PHASE3","title":"FOLFIRI or FOLFOX With or Without Cetuximab in Patients With Metastatic Adenocarcinoma of the Colon or Rectum","status":"TERMINATED","sponsor":"Alliance for Clinical Trials in Oncology","startDate":"2003-12","conditions":"Colorectal Cancer","enrollment":238},{"nctId":"NCT00098839","phase":"PHASE1, PHASE2","title":"Chemoimmunotherapy With Epratuzumab in Relapsed Acute Lymphoblastic Leukemia (ALL)","status":"COMPLETED","sponsor":"Children's Oncology Group","startDate":"2005-02","conditions":"Recurrent Childhood Acute Lymphoblastic Leukemia","enrollment":134},{"nctId":"NCT02606539","phase":"PHASE2, PHASE3","title":"Surgery Plus Single Agent Chemotherapy Versus Primary Chemotherapy for Gestational Trophoblastic Neoplasms","status":"UNKNOWN","sponsor":"Maher elesawi kamel elesawi","startDate":"2015-09","conditions":"Gestational Trophoblastic Neoplasms","enrollment":20},{"nctId":"NCT00873093","phase":"PHASE2","title":"Bortezomib and Combination Chemotherapy in Treating Young Patients With Relapsed Acute Lymphoblastic Leukemia or Lymphoblastic Lymphoma","status":"COMPLETED","sponsor":"National Cancer Institute (NCI)","startDate":"2009-03","conditions":"B-cell Adult Acute Lymphoblastic Leukemia, B-cell Childhood Acute Lymphoblastic Leukemia, Recurrent Adult Acute Lymphoblastic Leukemia","enrollment":148},{"nctId":"NCT00098774","phase":"PHASE2","title":"Rituximab and Combination Chemotherapy in Treating Patients With Newly Diagnosed Primary CNS Lymphoma","status":"COMPLETED","sponsor":"Alliance for Clinical Trials in Oncology","startDate":"2004-10","conditions":"Lymphoma","enrollment":47},{"nctId":"NCT00003700","phase":"PHASE2","title":"Combination Chemotherapy in Treating Patients With Untreated Acute Lymphoblastic Leukemia","status":"COMPLETED","sponsor":"Alliance for Clinical Trials in Oncology","startDate":"1999-01","conditions":"Leukemia","enrollment":163},{"nctId":"NCT00941174","phase":"PHASE1","title":"Folate Absorption Across the Large Intestine","status":"COMPLETED","sponsor":"The Hospital for Sick Children","startDate":"2008-09","conditions":"Healthy","enrollment":9},{"nctId":"NCT00112918","phase":"PHASE3","title":"Combination Chemotherapy With or Without Bevacizumab in Treating Patients Who Have Undergone Surgery for High Risk Stage II or Stage III Colon Cancer","status":"COMPLETED","sponsor":"Hoffmann-La Roche","startDate":"2004-12","conditions":"Colorectal Cancer","enrollment":3451},{"nctId":"NCT00002551","phase":"PHASE3","title":"SWOG-9304 Chemotherapy Plus Radiation Therapy in Treating Patients With Rectal Cancer That Has Been Surgically Removed","status":"COMPLETED","sponsor":"SWOG Cancer Research Network","startDate":"1994-03","conditions":"Colorectal Cancer","enrollment":1917},{"nctId":"NCT00000724","phase":"PHASE3","title":"A Study of Trimetrexate With Leucovorin Rescue for AIDS Patients Who Are Refractory to Standard Therapies for Pneumocystis Carinii Pneumonia","status":"COMPLETED","sponsor":"National Institute of Allergy and Infectious Diseases (NIAID)","startDate":"","conditions":"Pneumonia, Pneumocystis Carinii, HIV Infections","enrollment":""},{"nctId":"NCT00786643","phase":"PHASE2","title":"Study of Gamma Interfereon in Metastatic Colorectal Carcinoma","status":"COMPLETED","sponsor":"Accelerated Community Oncology Research Network","startDate":"2006-02","conditions":"Colorectal Cancer","enrollment":48},{"nctId":"NCT00677612","phase":"PHASE1, PHASE2","title":"Histocompatibility Leukocyte Antigen (HLA)-A*0201 Restricted Peptide Vaccine Therapy in Patients With Colorectal Cancer","status":"TERMINATED","sponsor":"Tokyo University","startDate":"2008-05","conditions":"Colorectal Cancer, Colon Cancer, Rectal Cancer","enrollment":14},{"nctId":"NCT00677287","phase":"PHASE1, PHASE2","title":"Histocompatibility Leukocyte Antigen (HLA)-A*2402 Restricted Peptide Vaccine Therapy in Patients With Colorectal Cancer","status":"TERMINATED","sponsor":"Tokyo University","startDate":"2008-05","conditions":"Colorectal Cancer, Colon Cancer, Rectal Cancer","enrollment":14},{"nctId":"NCT00001016","phase":"PHASE3","title":"A Treatment Protocol for the Use of Trimetrexate With Leucovorin Rescue for AIDS Patients With Pneumocystis Carinii Pneumonia and Serious Intolerance to Approved Therapies","status":"COMPLETED","sponsor":"National Institute of Allergy and Infectious Diseases (NIAID)","startDate":"","conditions":"Pneumonia, Pneumocystis Carinii, HIV Infections","enrollment":""}],"_emaApprovals":[],"_faersSignals":[],"_approvalHistory":[],"publicationCount":1,"rwe":[],"genericFilers":[],"relatedDrugs":[],"labelChanges":[],"biosimilarFilings":[],"pricing":[],"formularyStatus":[],"manufacturing":[],"companionDiagnostics":[],"competitors":[],"timeline":[],"patents":[],"ownershipHistory":[],"trials":[],"biosimilars":[],"latestUpdates":[],"references":[],"tags":[],"ecosystem":[],"genericManufacturerList":[],"offLabel":[],"developmentCodes":[],"aliases":["Folinic Acid","Leucovorin, leucovorin","Leucovorin","LV","Calcium levofolinate"],"phase":"phase_3","status":"active","brandName":"Calcium Folinate Injection","genericName":"Calcium Folinate Injection","companyName":"Suzhou Suncadia Biopharmaceuticals Co., Ltd.","companyId":"suzhou-suncadia-biopharmaceuticals-co-ltd","modality":"Small molecule","firstApprovalDate":"","aiSummary":"Calcium folinate is a reduced form of folic acid that acts as a cofactor in one-carbon transfer reactions, supporting DNA synthesis and cell division. Used for Methotrexate toxicity rescue in high-dose methotrexate chemotherapy, Adjunctive therapy in colorectal cancer and other malignancies, Megaloblastic anemia due to folate deficiency.","enrichmentLevel":3,"visitCount":0,"trialStats":{"total":0,"withResults":0},"verificationStatus":"verified","dataCompleteness":{"mechanism":true,"indications":true,"safety":true,"trials":true,"score":4}}